Table Of Content

Advances in Contraception. 1993;9:369. © 1993 Kluwer Academic Publishers. Printed in the Netherlands Author Index to Volume 9 S1 denotes Volume 9 Supplement 1 (in Spanish) AbarcaL 285, 291 GuidaM 335 Petersen KR §1:49 Adinma JIB 341 GirlerS 299 Poindexter AN 161, 227 Aral K 251, 299, 313 Gutiérrez A S1:3 Pollack AE 181 Back DJ 319 Hadjar LNE 33 Porter Jr CW 83 BarbatoM 335 Hagay Z 331 PowerJ 319 BarriP N 71 Hammerstein J 319 Prihyugiharto T 33 Bateman L161, 227 HuezoC 129 Ratnam SS 41, 49, 233, Borenstein R 331 Iglesias L 363 241 Bruyniks N 13, 93, 351 Jespersen J §1:49 Remennick L 13, 93 Butini P 195 Ketting E 105, 141, 351 Rios M_ 285, 291 CarrerasO 71 Kirkman RJ E 81:59 Runenbaum B_ S1:65 Castro A 285, 291 Kivijarvi A 65 Rusbandi 215 CavionMA 195 Lachnit-Fixson U 187 Schindler AE 319 Chatterton R T 257 Ladipo OA 25 Simon A 319 Chil-C 205 Lehert P 13, 141 Singh K 41, 49, 233, 241 Cobanoglu O 251, 299, Loke DFM 41, 49, 233 SkoubySO 81:49 313 Londofo D S1:3 Spinelli A 153 ColombiniG 195 Lu Y-C 257 SponaJ 187 Daume E 319 Lurie S 331 Taberner D 75 DiazJ 117 ManuabaIBG 303 ThomasDB S1:31 DiazM 117 ManubensM 71 Thorogood M_ S1:19 DiazS 129, §1:13 Martinez F 71 TurR 71 van Dierendonck B 25 MassafraC 195 UK Family Planning Dobianer K 187 MeddaE 153 Research Network DonatiS 153 MinutoS M 195 59 Disterberg B 187 Nahmonovici C 65 UlasiJ N 25 EdelmanDA 83 Neiss A 319 UrdinolaJ S$1:3 Ekwempu CC 25 Noerpramana N P 215 UzelR 141, 351 Elstein M §$1:65 de Nooyer CCA 65 VemerHM 105 European Natural Family Oddens BJ 1, 105, 351 ViegasO AC 41, 49, Planning Study OguzS 313 233, 241 Groups 269 Okeke AO 341 Visser AP 13, 93, 105, Frank ML 161, 227 vanOsWAA 65 141, 351 Giwa-Osagie OF 25 Oyediran MA 175 WebbA 75 Gokmen O 251, 299, PandiS P 33 Winkler U 319 313 Pandolfi A 335 Yakupoglu H 313 Grandolfo M 153 PavienkoI 13 ZorluC G 251, 299, 313 Advances in Contraception. 1993;9:370. © 1993 Kluwer Academic Publishers. Printed in the Netherlands Title Index to Volume 9 S1 denotes Volume 9 Supplement 1 Attitudes of Czech and Slovak gynecologists towards family planning 351 The clinical performance of the Multiload IUD. I. The influence of the endometrial cavity length 285 The clinical performance of the Multiload IUD. II. The influence of age 291 Clotting factors after emergency contraception 75 Contraception in Germany: a review 105 Contraception in Spain 363 Contraceptive practice and attitudes in former Soviet women 13 Effects of the antiestrogen anordiol on ovulation and endometrial histology in the rat 257 Evaluation of hemostatic function following Norplant implant removal 49 Evaluation of hemostatic function following Norplant-2 rods removal 241 Evaluation of liver function and lipid metabolism following Norplant implant removal 41 Evaluation of liver function and lipid metabolism following Norplant-2 rods removal 233 Evaluation of risk of thrombosis during use of low-dose ethinylestradiol—-desogestrel oral contraceptive 195 Evaluation of the effect of contraceptive prices on demand in eight Western European countries 1 Extraovular PGE, and oxytocin-implicated uterine rupture during midtrimester termination of pregnancy 331 Factors associated with the choice of Norplant by women attending subsidized clinics inthe US 161 Factors influencing attitude about Norplant contraceptive subdermal implant 215 Family planning in Italy 153 Family planning in Russia: experiences and attitudes of gynecologists 93 Health benefits of oral contraceptives [in Spanish] $1: 13 The importance of training and supervision in quality of care 175 Inhibition of ovulation by a triphasic gestodene containing oral contraceptive 187 Intracervical anchoring: a new approach to intrauterine contraception 65 Introductory trial of the once-a-month injectable contraceptive, Cyclofem, in Indonesia 33 IUD (CuT380A) insertion following induced first trimester abortion 251 Metabolic effects of oral contraceptives [in Spanish] $1: 49 A multicenter clinical trial in Nigeria with a low-dose oral contraceptive, Marvelon 25 A multicenter study of the clinical performance of the Ortho Gyne-T380 Slimline intrauterine device in routine use in general practice and family planning clinics 59 A new diagnostic aid for natural family planning 335 The new intrauterine contraceptive devices: safe and effective 83 Nontraumatic tubal occlusion as a new technique for female voluntary sterilization 303 Oral contraception in the former Czech and Slovak Federal Republic: attitudes and use 141 Oral contraceptives and cancer [in Spanish] $1: 31 Oral contraceptives and cardiovascular disease [in Spanish] S1: 19 Oral contraceptives and women over 35 [in Spanish] $1: 59 Oral contraceptives in Latin America [in Spanish] $1: 3 Ovarian function during hormonal replacement therapy in perimenopausal women 71 Overall assessment of oral contraception [in Spanish] S1: 65 Pelvic inflammatory disease and intrauterine devices: prophylactic antibiotics to reduce febrile complications 299 Pharmacokinetics and protein binding of 3-ketodesogestrel and gestodene in the serum of women during 6 cycles of treatment with two low dose oral contraceptives 319 The pill: perceptions and usage among Nigerian students 341 Planned condom use by women with Norplant implants 227 Prospective European multi-center study of natural family planning (1989-1992) - interim results 269 Quality of care in family planning in Latin America 117 Quality of care in family planning: clients’ rights and providers’ needs 129 Some methodological considerations of a progestin-only oral contraceptive study from a programmatic perspective 205 Tubal sterilization by laparoscopy and minilaparotomy 313 Vasectomy and prostate cancer 181